| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
a University Hospital
Maastricht, The Netherlands, b TNO-PG, Leiden, The
Netherlands, c Maasland Ziekenhuis, Sittard, The Netherlands
Correspondence to: Dr Boonen, Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands aboo{at}SINT.AZM.NL
Accepted for publication 7 August 2000
OBJECTIVE
To evaluate
employment status, work disability, and work days lost in patients with
ankylosing spondylitis (AS).
METHODSA
questionnaire was sent to 709 patients with AS aged 16-60. The results
of 658 of the patients could be analysed.
RESULTSAfter
adjustment for age, labour force participation was decreased by 15.4%
in male patients and 5.2% in female patients compared with the general
Dutch population. Work disability (all causes) was 15.7% and 16.9%
higher than expected in the general population for male and female
patients respectively. In particular, the proportion of those with a
partial work disability pension was increased. Patients with a paid job
lost 5.0% of work days as the result of having AS, accounting for a
mean of 10.1 days of sick leave due to AS per patient per year in
addition to the national average of 12.3 unspecified days of sick leave.
CONCLUSIONThis study
on work status in AS provides data adjusted for age and sex, and the
differences from the reference population were significant. The impact
of AS on employment and work disability is considerable. Work status in
patients with AS needs more attention as an outcome measure in future research.
This article has been cited by other articles:
|
|
 |
|
  E. K. Li, J. F. Griffith, V. W. Lee, Y.-X. Wang, T. K. Li, K. K. Lee, and L.-S. Tam Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation Rheumatology, September 1, 2008; 47(9): 1358 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Braun, X Baraliakos, J Listing, C Fritz, R Alten, G Burmester, A Krause, S Schewe, M Schneider, H Sorensen, et al. Persistent clinical efficacy and safety of anti-tumour necrosis factor {alpha} therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response Ann Rheum Dis, March 1, 2008; 67(3): 340 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Barkham, K. O. Kong, A. Tennant, A. Fraser, E. Hensor, A. M. Keenan, and P. Emery The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis Rheumatology, October 1, 2005; 44(10): 1277 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Listing, J Brandt, M Rudwaleit, A Zink, J Sieper, and J Braun Impact of anti-tumour necrosis factor {alpha} treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis Ann Rheum Dis, December 1, 2004; 63(12): 1670 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Boonen, D van der Heijde, R Landewe, A Chorus, W van Lankveld, H Miedema, H van der Tempel, and S van der Linden Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis? Ann Rheum Dis, October 1, 2004; 63(10): 1264 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M J Chorus, H S Miedema, A Boonen, and S. van der Linden Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age Ann Rheum Dis, December 1, 2003; 62(12): 1178 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Pham, D van der Heijde, A Calin, M A Khan, S. van der Linden, N Bellamy, and M Dougados Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group Ann Rheum Dis, September 1, 2003; 62(9): 812 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Braun, T Pham, J Sieper, J Davis, S. van der Linden, M Dougados, and D van der Heijde International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis Ann Rheum Dis, September 1, 2003; 62(9): 817 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Boonen, D van der Heijde, R Landewe, F Guillemin, M Rutten-van Molken, M Dougados, H Mielants, K de Vlam, H van der Tempel, S Boesen, et al. Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries Ann Rheum Dis, August 1, 2003; 62(8): 732 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Sieper, J Braun, M Rudwaleit, A Boonen, and A Zink Ankylosing spondylitis: an overview Ann Rheum Dis, November 1, 2002; 61(90003): iii8 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Braun, D van der Heijde, M Dougados, P Emery, M A Khan, J Sieper, and S. van der Linden Staging of patients with ankylosing spondylitis: a preliminary proposal Ann Rheum Dis, November 1, 2002; 61(90003): iii19 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M J Chorus, A Boonen, H S Miedema, and S. van der Linden Employment perspectives of patients with ankylosing spondylitis Ann Rheum Dis, August 1, 2002; 61(8): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Boonen, A Chorus, R Landewe, D van der Heijde, H Miedema, H van der Tempel, and S. van der Linden Manual jobs increase the risk of patients with ankylosing spondylitis withdrawing from the labour force, also when adjusted for job related withdrawal in the general population Ann Rheum Dis, July 1, 2002; 61(7): 658 - 658. [Full Text]
|
|
|
|
|
|
A Boonen, D van der Heijde, R Landewe, A Spoorenberg, H Schouten, M Rutten-Van Molken, F Guillemin, M Dougados, H Mielants, K de Vlam, et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries Ann Rheum Dis, May 1, 2002; 61(5): 429 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Boonen, A Chorus, H Miedema, D van der Heijde, R Landewe, H Schouten, H van der Tempel, and S van der Linden Withdrawal from labour force due to work disability in patients with ankylosing spondylitis Ann Rheum Dis, November 1, 2001; 60(11): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Sieper and J Braun New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy Ann Rheum Dis, November 1, 2001; 60(90003): iii58 - 61. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
